Megha Saraswat

1.0k total citations
9 papers, 851 citations indexed

About

Megha Saraswat is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism and Cell Biology. According to data from OpenAlex, Megha Saraswat has authored 9 papers receiving a total of 851 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Clinical Biochemistry, 5 papers in Endocrinology, Diabetes and Metabolism and 4 papers in Cell Biology. Recurrent topics in Megha Saraswat's work include Advanced Glycation End Products research (6 papers), Natural Antidiabetic Agents Studies (5 papers) and Aldose Reductase and Taurine (4 papers). Megha Saraswat is often cited by papers focused on Advanced Glycation End Products research (6 papers), Natural Antidiabetic Agents Studies (5 papers) and Aldose Reductase and Taurine (4 papers). Megha Saraswat collaborates with scholars based in India. Megha Saraswat's co-authors include G. Bhanuprakash Reddy, Palla Suryanarayana, J. Mark Petrash, T. Mrudula, Puppala Muthenna, Kamala Krishnaswamy, T. Prasanna Krishna, P. Yadagiri Reddy, Anil Kumar Pasupulati and Nagalla Balakrishna and has published in prestigious journals such as British Journal Of Nutrition, Investigative Ophthalmology & Visual Science and Pharmacological Reports.

In The Last Decade

Megha Saraswat

9 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Megha Saraswat India	9	359	318	258	212	159	9	851
Puppala Muthenna India	11	293 0.8×	238 0.7×	168 0.7×	168 0.8×	69 0.4×	14	683
Elango Bhakkiyalakshmi India	16	223 0.6×	60 0.2×	478 1.9×	83 0.4×	133 0.8×	20	946
Pidaran Murugan India	13	349 1.0×	63 0.2×	251 1.0×	32 0.2×	152 1.0×	21	822
Elisabeth Wenzel Germany	9	96 0.3×	171 0.5×	361 1.4×	27 0.1×	256 1.6×	11	1.1k
Hong Yan China	19	57 0.2×	133 0.4×	230 0.9×	33 0.2×	153 1.0×	30	859
Eun Jin Sohn South Korea	18	131 0.4×	94 0.3×	297 1.2×	28 0.1×	47 0.3×	22	784
Osasenaga Macdonald Ighodaro Nigeria	7	274 0.8×	77 0.2×	175 0.7×	23 0.1×	129 0.8×	10	709
Jarinyaporn Naowaboot Thailand	15	308 0.9×	42 0.1×	395 1.5×	31 0.1×	204 1.3×	40	1.0k
Mohamed B. Ashour Egypt	12	312 0.9×	37 0.1×	241 0.9×	28 0.1×	89 0.6×	16	836
Weerachat Sompong Thailand	13	354 1.0×	260 0.8×	118 0.5×	18 0.1×	105 0.7×	14	690

Countries citing papers authored by Megha Saraswat

Since Specialization

Citations

This map shows the geographic impact of Megha Saraswat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megha Saraswat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megha Saraswat more than expected).

Fields of papers citing papers by Megha Saraswat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megha Saraswat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megha Saraswat. The network helps show where Megha Saraswat may publish in the future.

Co-authorship network of co-authors of Megha Saraswat

This figure shows the co-authorship network connecting the top 25 collaborators of Megha Saraswat. A scholar is included among the top collaborators of Megha Saraswat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megha Saraswat. Megha Saraswat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Saraswat, Megha, et al.. (2014). Renoprotective activity of aliskiren, a renin inhibitor in cyclosporine A induced hypertensive nephropathy in dTG mice. Pharmacological Reports. 66(1). 62–67. 8 indexed citations

Muthenna, Puppala, et al.. (2011). Inhibition of advanced glycation end-product formation on eye lens protein by rutin. British Journal Of Nutrition. 107(7). 941–949. 54 indexed citations

Saraswat, Megha, Palla Suryanarayana, P. Yadagiri Reddy, et al.. (2010). Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats.. PubMed. 16. 1525–37. 74 indexed citations

Saraswat, Megha, P. Yadagiri Reddy, Puppala Muthenna, & G. Bhanuprakash Reddy. (2008). Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications. British Journal Of Nutrition. 101(11). 1714–1721. 79 indexed citations

Saraswat, Megha, Puppala Muthenna, Palla Suryanarayana, J. Mark Petrash, & G. Bhanuprakash Reddy. (2008). Dietary sources of aldose reductase inhibitors: prospects for alleviating diabetic complications.. PubMed. 17(4). 558–65. 86 indexed citations

Suryanarayana, Palla, Megha Saraswat, J. Mark Petrash, & G. Bhanuprakash Reddy. (2007). Emblica officinalis and its enriched tannoids delay streptozotocin-induced diabetic cataract in rats.. PubMed. 13. 1291–7. 104 indexed citations

Saraswat, Megha, et al.. (2006). Overexpression of aldose reductase in human cancer tissues.. PubMed. 12(12). CR525–529. 61 indexed citations

Suryanarayana, Palla, Megha Saraswat, T. Mrudula, et al.. (2005). Curcumin and Turmeric Delay Streptozotocin-Induced Diabetic Cataract in Rats. Investigative Ophthalmology & Visual Science. 46(6). 2092–2092. 253 indexed citations

Suryanarayana, Palla, Anil Kumar Pasupulati, Megha Saraswat, J. Mark Petrash, & G. Bhanuprakash Reddy. (2004). Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract.. PubMed. 10. 148–54. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact